300601 fundamentals
SHENZHEN KANGTAI B revenue breakdown overview
SHENZHEN KANGTAI B revenue for the last year amounted to 3.48 B CNY, the most of which — 3.44 B CNY — came from its highest performing source at the moment, Non-immunization Program Vaccines, the year earlier bringing 2.90 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought SHENZHEN KANGTAI B 3.48 B CNY, and the year before that — 3.16 B CNY.
By source
2016
2017
2018
2019
2020
2021
2022
2023
0.00
1.00 B
2.00 B
3.00 B
4.00 B
Non-immunization Program Vaccines
Immunization Program Vaccines
Other Business
Currency: CNY
2016
2017
2018
2019
2020
2021
2022
2023
Non-immunization Program Vaccines
1.85 B
2.23 B
2.49 B
2.90 B
3.44 B
Immunization Program Vaccines
95.58 M
28.83 M
1.16 B
227.52 M
25.03 M
Other Business
970.99 K
2.32 M
2.33 M
28.11 M
11.16 M
By country
2016
2017
2018
2019
2020
2021
2022
2023
0.00
1.00 B
2.00 B
3.00 B
4.00 B
China
Currency: CNY
2016
2017
2018
2019
2020
2021
2022
2023
China
1.94 B
2.26 B
3.65 B
3.16 B
3.48 B